Purine derivatives
    3.
    发明授权
    Purine derivatives 失效
    嘌呤衍生物

    公开(公告)号:US06525032B2

    公开(公告)日:2003-02-25

    申请号:US09789236

    申请日:2001-02-20

    IPC分类号: A61K3170

    摘要: The present invention relates to compounds of the class of purin-2-ylcarboxamides, useful as anti-inflammatory agents, having the formula: and pharmaceutically acceptable salts and solvates thereof; wherein R1 is H, C1-C 6 alkyl or C3-C7 cycloalkyl, each optionally substituted by 1 or 2 of hydroxyl, fluorenyl, or optionally substituted phenyl or naphthyl ; A is a bond or C1-C6 alkylene; R2 is (i) H, C1-C6 alkyl, or optionally substituted C3-C7 cycloalkyl, phenyl, or naphthyl; or (ii) when A is C2-C6 alkylene, —NR3R3, —OR3, —COOR3, —OCOR4, —SO2R4, —CN, —SO2NR3R4, —NR3SO2R4, —NR3COR4 or —CONR3R3; or (iii) a C-linked, 4 to 11 membered, mono or bicyclic heterocycle having either from 1 to 4 ring nitrogen atom(s) or 1 or 2 nitrogen and 1 oxygen or 1 sulphur ring atoms, said heterocycle being optionally C-substituted or N-substituted; or (iv) when A is C2-C6 alkylene, optionally substituted N-linked azetidinyl, pyrrolidinyl, morpholinyl, tetrahydroisoquinolinyl, piperidinyl or piperazinyl; R7 is H, C1-C6 alkyl, C3-C7 cycloalkyl, phenyl, naphthyl, azetidin-3-yl, pyrrolidin-3-yl, piperidin-3-yl, piperidin-4-yl, or het; and R8 is H or C1-C6 alkyl; and to intermediates used in processes for the preparation of, compositions containing, and uses as adenosine A2a receptor agonists of, compounds of formula (I).

    摘要翻译: 本发明涉及可用作抗炎剂的具有下式的嘌呤-2-基甲酰胺类化合物及其药学上可接受的盐和溶剂合物: 其中R 1是H,C 1 -C 6烷基或C 3 -C 7环烷基,各自任选被1或2个羟基,芴基或任选取代的苯基或萘基取代; A是键或C1-C6亚烷基; R 2是(i)H,C 1 -C 6烷基或任选取代的C 3 -C 7环烷基,苯基或萘基; 或(ii)当A是C 2 -C 6亚烷基,-NR 3 R 3,-OR 3,-COOR 3,-OCOR 4,-SO 2 R 4,-CN,-SO 2 NR 3 R 4,-NR 3 SO 2 R 4,-NR 3 COR 4或-CONR 3 R 3时; 或(iii)具有1至4个环氮原子或1或2个氮和1个氧或1个硫环原子的C连接的4至11元单环或双环杂环,所述杂环任选为C- 取代或N-取代的; 或(iv)当A为C 2 -C 6亚烷基时,任选取代的N-连接的氮杂环丁烷基,吡咯烷基,吗啉基,四氢异喹啉基,哌啶基或哌嗪基; R 7是H,C 1 -C 6烷基,C 3 -C 7环烷基,苯基,萘基,氮杂环丁烷-3-基,吡咯烷-3-基,哌啶-3-基,哌啶-4-基或咔唑; 且R 8为H或C 1 -C 6烷基; 以及用于制备含有和用作式(I)化合物的腺苷A2a受体激动剂的组合物的方法中使用的中间体。

    Quinolines and quinazolines useful in therapy
    4.
    发明授权
    Quinolines and quinazolines useful in therapy 失效
    喹啉和喹唑啉可用于治疗

    公开(公告)号:US06417194B1

    公开(公告)日:2002-07-09

    申请号:US09499623

    申请日:2000-02-07

    IPC分类号: A61K3147

    摘要: Compounds of formula I, wherein R1 represents C1-4 alkoxy optionally substituted by one or more fluorine atoms; R2 and R3 independently represent H or C1-6 alkoxy (which is optionally substituted); R4 represents a 4-, 5-, 6- or 7-membered heterocyclic ring, the ring being optionally fused to a benzene ring or a 5- or 6-membered heterocyclic, the ring system as a whole being optionally substituted; X represents CH or N; and L is absent, or represents a cyclic group of formula Ia, or represents a chain of formula Ib, and pharmaceutically acceptable salts thereof; are useful in therapy, in particular in the treatment of benign prostatic hyperplasia.

    摘要翻译: 式I化合物,其中R 1表示任选被一个或多个氟原子取代的C 1-4烷氧基; R 2和R 3独立地表示H或C 1-6烷氧基(其任选被取代); R 4表示4-,5-,6-或 所述环任选地与苯环或5-或6-元杂环稠合,所述环系统作为整体任选被取代; X表示CH或N; 并且L不存在,或表示式Ia的环状基团,或表示式Ib的链及其药学上可接受的盐; 可用于治疗,特别是治疗良性前列腺增生。

    ISOCYSTENE DERIVATIVES FOR THE TREATMENT OF PAIN
    5.
    发明申请
    ISOCYSTENE DERIVATIVES FOR THE TREATMENT OF PAIN 审中-公开
    用于治疗疼痛的异体衍生物

    公开(公告)号:US20090286875A1

    公开(公告)日:2009-11-19

    申请号:US12093475

    申请日:2006-11-09

    IPC分类号: A61K31/27 C07C261/00

    摘要: The present invention relates to compounds of formula (I): wherein R1, R2, R4 and R4a are as defined herein. The invention also relates to the use of compounds of formula (I) for the treatment of pain.

    摘要翻译: 本发明涉及式(I)化合物:其中R1,R2,R4和R4a如本文所定义。 本发明还涉及式(I)化合物用于治疗疼痛的用途。

    Amino Acid Derivatives
    8.
    发明申请
    Amino Acid Derivatives 审中-公开
    氨基酸衍生物

    公开(公告)号:US20090227680A1

    公开(公告)日:2009-09-10

    申请号:US12093503

    申请日:2006-11-06

    IPC分类号: A61K31/195 C07C62/00

    CPC分类号: C07C229/22

    摘要: The present invention relates to a method of treating pain using a compound of formula (I), wherein Ar, R1, R3 and R3a are as defined herein. The invention also relates to certain novel compounds of formula (I).

    摘要翻译: 本发明涉及使用式(I)化合物治疗疼痛的方法,其中Ar,R 1,R 3和R 3a如本文所定义。 本发明还涉及某些新的式(I)化合物。